Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05925322 · ClinicalTrials.gov registry record · NA

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

A NA study of Depression and Major Depressive Disorder, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT05925322 is a NA study of Depression and Major Depressive Disorder that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 128 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05925322, a NA study of Depression and Major Depressive Disorder, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesized that during the 9-week course of Engage \& Connect treatment there will be an increase in brain functions of the Positive Valence System which in turn will lead to reduction in suicidality.

Interventions

  • BEHAVIORAL "Engage & Connect" Psychotherapy
  • BEHAVIORAL Symptom Review and Psychoeducation (SRP)

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2023-09-18
Est. Completion 2028-09-30
Phase NA

What the Registry Record Tells You About NCT05925322

The ClinicalTrials.gov registry entry for NCT05925322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (84% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which "Engage & Connect" Psychotherapy is the first listed.

NCT05925322 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05925322 about?

NCT05925322 is a clinical study titled "Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality". The investigators hypothesized that during the 9-week course of Engage \& Connect treatment there will be an increase in brain functions of the Positive Valence System which in turn will lead to reduction in suicidality.

What is the current status of trial NCT05925322?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2023-09-18. Estimated completion is 2028-09-30.

What conditions does trial NCT05925322 study?

This clinical trial studies the following conditions: Depression, Major Depressive Disorder, Suicidal Ideation, Depressive Disorder.

What interventions are being tested in trial NCT05925322?

The interventions under investigation include: "Engage & Connect" Psychotherapy (BEHAVIORAL), Symptom Review and Psychoeducation (SRP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05925322?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05925322 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.